Arti Devi, Chandra Shekhar Saini, Aditya Shiven, Ashwani Kumar, Anisha Sharma, Naman Joshi, Sajpreet Kour, Zaved Ahmed Khan, Hitesh Dewangan, Vagish Dwibedi
{"title":"Unconventional Non-rodent Models in Neurological Research: Exploring New Paths to Translational Insights","authors":"Arti Devi, Chandra Shekhar Saini, Aditya Shiven, Ashwani Kumar, Anisha Sharma, Naman Joshi, Sajpreet Kour, Zaved Ahmed Khan, Hitesh Dewangan, Vagish Dwibedi","doi":"10.1007/s12031-025-02408-6","DOIUrl":null,"url":null,"abstract":"<div><p>Neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), Schizophrenia (SCZ), and epilepsy pose a significant global health challenge, particularly among the ageing population. With Alzheimer’s cases projected to double in the next 30 years, the lack of effective treatments presents a critical concern, leading to substantial social and economic burdens. While rodent models have been instrumental in elucidating disease mechanisms and identifying therapeutic targets, their limited translational success necessitates exploring alternative model systems. This review highlights the increasing integration of non-rodent models, including invertebrates (<i>Drosophila melanogaster</i> and <i>Caenorhabditis elegans</i>), lower vertebrates (<i>Danio rerio</i>), and higher-order mammals (non-human primates), alongside emerging approaches such as <i>Octopus</i> models, 2D and 3D cell culture systems, computational models, and in silico methodologies. These alternative models provide unique advantages in studying neural development, function, and pathology, offering improved translational relevance. By leveraging the complementary strengths of these systems, researchers can refine therapeutic strategies and advance our understanding of complex neurological disorders.</p><h3>Graphical Abstract</h3>\n<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":652,"journal":{"name":"Journal of Molecular Neuroscience","volume":"75 4","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Molecular Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12031-025-02408-6","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), Schizophrenia (SCZ), and epilepsy pose a significant global health challenge, particularly among the ageing population. With Alzheimer’s cases projected to double in the next 30 years, the lack of effective treatments presents a critical concern, leading to substantial social and economic burdens. While rodent models have been instrumental in elucidating disease mechanisms and identifying therapeutic targets, their limited translational success necessitates exploring alternative model systems. This review highlights the increasing integration of non-rodent models, including invertebrates (Drosophila melanogaster and Caenorhabditis elegans), lower vertebrates (Danio rerio), and higher-order mammals (non-human primates), alongside emerging approaches such as Octopus models, 2D and 3D cell culture systems, computational models, and in silico methodologies. These alternative models provide unique advantages in studying neural development, function, and pathology, offering improved translational relevance. By leveraging the complementary strengths of these systems, researchers can refine therapeutic strategies and advance our understanding of complex neurological disorders.
期刊介绍:
The Journal of Molecular Neuroscience is committed to the rapid publication of original findings that increase our understanding of the molecular structure, function, and development of the nervous system. The criteria for acceptance of manuscripts will be scientific excellence, originality, and relevance to the field of molecular neuroscience. Manuscripts with clinical relevance are especially encouraged since the journal seeks to provide a means for accelerating the progression of basic research findings toward clinical utilization. All experiments described in the Journal of Molecular Neuroscience that involve the use of animal or human subjects must have been approved by the appropriate institutional review committee and conform to accepted ethical standards.